Cargando…
Adverse outcome pathway development from protein alkylation to liver fibrosis
In modern toxicology, substantial efforts are undertaken to develop alternative solutions for in vivo toxicity testing. The adverse outcome pathway (AOP) concept could facilitate knowledge-based safety assessment of chemicals that does not rely exclusively on in vivo toxicity testing. The constructi...
Autores principales: | Horvat, Tomislav, Landesmann, Brigitte, Lostia, Alfonso, Vinken, Mathieu, Munn, Sharon, Whelan, Maurice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364266/ https://www.ncbi.nlm.nih.gov/pubmed/27542122 http://dx.doi.org/10.1007/s00204-016-1814-8 |
Ejemplares similares
-
COVID-19 and the liver: an adverse outcome pathway perspective
por: Vinken, Mathieu
Publicado: (2021) -
Sex Differences in Liver Toxicity—Do Female and Male Human Primary Hepatocytes React Differently to Toxicants In Vitro?
por: Mennecozzi, Milena, et al.
Publicado: (2015) -
How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology
por: Wittwehr, Clemens, et al.
Publicado: (2017) -
Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework
por: Nymark, Penny, et al.
Publicado: (2021) -
Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment
por: Perkins, Edward J., et al.
Publicado: (2019)